Evidence map›Paper›PMID 37189453›Full record

ArticleBiomolecules2023

Dose-Dependent Effects in Plasma Oncotherapy: Critical In Vivo Immune Responses Missed by In Vitro Studies.

Yuanyuan He, Fanwu Gong, Tao Jin, Qi Liu, Haopeng Fang, Yan Chen, Guomin Wang, Paul K Chu, Zhengwei Wu, Kostya Ken Ostrikov

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Yuanyuan HeSchool of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China.
Fanwu GongDepartment of Medical Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei 230001, China.
Tao JinSchool of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China.
Qi LiuSchool of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China.
Haopeng FangDepartment of Medical Oncology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei 230001, China.
Yan ChenJoint Laboratory of Plasma Application Technology, Institute of Advanced Technology, University of Science and Technology of China, Hefei 230026, China.
Guomin WangDepartment of Orthopedics, School of Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China.
Paul K ChuDepartment of Physics, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong 999077, China.ORCID 0000-0002-5581-4883
Zhengwei WuSchool of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China.
Kostya Ken OstrikovSchool of Chemistry and Physics and QUT Centre for Biomedical Technologies, Queensland University of Technology (QUT), Brisbane, QLD 4000, Australia.
University of Science and Technology of China · CNCity University of Hong Kong · HKQueensland University of Technology · AUTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cold atmospheric plasma (CAP) generates abundant reactive oxygen and nitrogen species (ROS and RNS, respectively) which can induce apoptosis, necrosis, and other biological responses in tumor cells. However, the frequently observed different biological responses to in vitro and in vivo CAP treatments remain poorly understood. Here, we reveal and explain plasma-generated ROS/RNS doses and immune system-related responses in a focused case study of the interactions of CAP with colon cancer cells in vitro and with the corresponding tumor in vivo. Plasma controls the biological activities of MC38 murine colon cancer cells and the involved tumor-infiltrating lymphocytes (TILs). In vitro CAP treatment causes necrosis and apoptosis in MC38 cells, which is dependent on the generated doses of intracellular and extracellular ROS/RNS. However, in vivo CAP treatment for 14 days decreases the proportion and number of tumor-infiltrating CD8

Indexed as

B7-H1 AntigenColonic NeoplasmsPlasma GasesAnimalsCell Line, TumorImmunityMiceMice, Inbred C57BLNecrosisProgrammed Cell Death 1 ReceptorReactive Oxygen SpeciesTumor MicroenvironmentB7-H1 AntigenPlasma GasesProgrammed Cell Death 1 ReceptorReactive Oxygen Speciescold atmospheric plasmadose-dependent effectsin vitro and in vivo plasma treatmentsROS/RNStumor microenvironment

Identifiers

PMID37189453
PMCPMC10136314
OpenAlexW4366773353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.